GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $208,000 | -32.9% | 5,071 | -37.7% | 0.28% | -3.1% |
| Q3 2018 | $310,000 | -39.2% | 8,146 | -27.8% | 0.29% | -37.9% |
| Q2 2018 | $510,000 | -9.9% | 11,278 | -3.7% | 0.47% | -21.2% |
| Q1 2018 | $566,000 | -26.3% | 11,711 | -40.0% | 0.59% | -24.5% |
| Q4 2017 | $768,000 | +41.4% | 19,516 | +11.6% | 0.78% | +18.0% |
| Q3 2017 | $543,000 | – | 17,492 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |